"Solubility" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
| Descriptor ID |
D012995
|
| MeSH Number(s) |
G02.805
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Solubility".
Below are MeSH descriptors whose meaning is more specific than "Solubility".
This graph shows the total number of publications written about "Solubility" by people in this website by year, and whether "Solubility" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 4 | 4 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 4 | 4 |
| 2003 | 0 | 7 | 7 |
| 2004 | 0 | 4 | 4 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 6 | 6 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 6 | 6 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 5 | 5 |
| 2013 | 0 | 3 | 3 |
| 2014 | 0 | 5 | 5 |
| 2015 | 0 | 6 | 6 |
| 2016 | 0 | 3 | 3 |
| 2017 | 1 | 8 | 9 |
| 2018 | 1 | 1 | 2 |
| 2019 | 0 | 7 | 7 |
| 2020 | 0 | 10 | 10 |
| 2021 | 0 | 5 | 5 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 2 | 2 |
| 2024 | 5 | 1 | 6 |
| 2025 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Solubility" by people in Profiles.
-
Decreased Crystal Plasticity by Solvation - the Case of Levofloxacin Acesulfame. Mol Pharm. 2025 Mar 03; 22(3):1598-1604.
-
Direct compression tablet formulation of trimetazidine through systematic screening of oxalate salts. Int J Pharm. 2025 Feb 25; 671:125255.
-
Simultaneously improving tabletability and solubility of diclofenac by cocrystallization with picolinamide. Int J Pharm. 2025 Feb 10; 670:125172.
-
Impact of route of particle engineering on dissolution performance of posaconazole. Int J Pharm. 2025 Jan 25; 669:125025.
-
Advancing the Harmonization of Biopredictive Methodologies through the Product Quality Research Institute (PQRI) Consortium: Biopredictive Dissolution of Dipyridamole Tablets. Mol Pharm. 2024 Oct 07; 21(10):5315-5325.
-
Efficient determination of critical water activity and classification of hydrate-anhydrate stability relationship. J Pharm Sci. 2025 Jan; 114(1):127-135.
-
Relative Bioavailability Assessment of Solid Forms by An Artificial Stomach and Duodenum Apparatus. J Pharm Sci. 2024 Aug; 113(8):2506-2512.
-
Delaying the first nucleation event of amorphous solid dispersions above the polymer overlap concentration (c*): PVP and PVPVA in posaconazole. J Pharm Sci. 2025 Jan; 114(1):98-104.
-
Development of direct compression Acetazolamide tablet with improved bioavailability in healthy human volunteers enabled by cocrystallization with p-Aminobenzoic acid. Int J Pharm. 2024 Mar 05; 652:123793.
-
Modulating Pharmaceutical Properties of Berberine Chloride through Cocrystallization with Benzendiol Isomers. Pharm Res. 2023 Dec; 40(12):2791-2800.